Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

NCT03902418 · clinicaltrials.gov ↗

COMPLETED

Status

1195

Enrollment

OTHER

Sponsor class

Conditions

HIV-I Infection

Interventions

DRUG: emtricitabine/tenofovir

Sponsor

University of California, Los Angeles

Collaborators

[object Object]